Last reviewed · How we verify
placebo like asacol — Competitive Intelligence Brief
marketed
Gastroenterology
Small molecule
Live · refreshed every 30 min
Target snapshot
placebo like asacol (placebo like asacol) — Tehran University of Medical Sciences. This is a placebo formulation designed to mimic Asacol (mesalamine) for use in clinical trials or comparative studies.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| placebo like asacol TARGET | placebo like asacol | Tehran University of Medical Sciences | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- placebo like asacol CI watch — RSS
- placebo like asacol CI watch — Atom
- placebo like asacol CI watch — JSON
- placebo like asacol alone — RSS
Cite this brief
Drug Landscape (2026). placebo like asacol — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-like-asacol. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab